How far would you go to save your child? For Mina Holland, her second baby became his sister’s saviour in the fight against a ...

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

Only a handful of stem cell therapies are currently approved by the F.D.A., mainly for treating blood cancer and immune ...

Researchers have identified an early postnatal window that allows gene transfer to circulating blood stem cells, advancing ...

The novel drug reduces the need for burdensome phlebotomy and also addresses fatigue, thereby improving quality of life for ...

De-Escalation of Bone-Modifying Agents in Patients With Bone Metastases: The Best of Times and the Worst of Times? The bone-modifying agents zoledronic acid, pamidronate, and denosumab have essential ...

The research so far indicates that BBGs frequently exhibit superior bioactivity and bone healing capacity compared to silicate glasses. They are also suitable candidates as drug delivery devices for ...

Skeletal stem cells (SSCs) have been isolated from various tissues, including periosteum and bone marrow, where they exhibit key functions in bone biology and hematopoiesis, respectively. The role of ...

8 In addition, a Phase 2 trial for subacute stroke reported that intravenous infusion of bone marrow–derived mononuclear cells was safe but had no effect on measures of neurological function. 9 A ...

Introduction: The objective of this case report is to describe a case of bone marrow suppression suspected to be secondary to febantel administration in a dog. Case summary: A 6-year-old neutered male ...